Clinical Trial

Study to Evaluate the Safety and Tolerability of PRO-190 Ophthalmic Solution Compared to Systane Ultra® on the Ocular Surface.

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a phase I clinical study to evaluate the safety and tolerability of PRO-190 ophthalmic solution through the incidence of unexpected adverse events, changes in Best Corrected Visual Acuity (BCVA), changes in ocular surface integrity, changes in the ocular comfort index (OCI) score, and IOP measurement compared to Systane Ultra®.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-04-17.
Trial Details
NCT Number NCT06379685
Lead Sponsor Laboratorios Sophia S.A de C.V.
Conditions Dry Eye, Dry Eyes Chronic, Dry Eye Syndromes
Enrollment 32 participants
Start Date 2025-12-30
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-19